Vaxevanis C, Bachmann M, Seliger B
J Immunother Cancer. 2024; 12(8).
PMID: 39209767
PMC: 11367391.
DOI: 10.1136/jitc-2024-009774.
Huang S, Qin Z, Wang F, Kang Y, Ren B
Oncol Rep. 2024; 52(4).
PMID: 39155864
PMC: 11358674.
DOI: 10.3892/or.2024.8796.
Cantoni C, Falco M, Vitale M, Pietra G, Munari E, Pende D
Oncoimmunology. 2024; 13(1):2378520.
PMID: 39022338
PMC: 11253890.
DOI: 10.1080/2162402X.2024.2378520.
Hartmann J, Cardoso M, Talarico M, Kenney D, Leone M, Reese D
Cell. 2024; 187(10):2393-2410.e14.
PMID: 38653235
PMC: 11088510.
DOI: 10.1016/j.cell.2024.03.026.
Toledo-Stuardo K, Ribeiro C, Campos I, Tello S, Latorre Y, Altamirano C
Front Genet. 2023; 14:1273296.
PMID: 38146340
PMC: 10749337.
DOI: 10.3389/fgene.2023.1273296.
Novel role of immune-related non-coding RNAs as potential biomarkers regulating tumour immunoresponse via MICA/NKG2D pathway.
Zhang J, Luo Q, Li X, Guo J, Zhu Q, Lu X
Biomark Res. 2023; 11(1):86.
PMID: 37784183
PMC: 10546648.
DOI: 10.1186/s40364-023-00530-4.
Reovirus infection of tumor cells reduces the expression of NKG2D ligands, leading to impaired NK-cell cytotoxicity and functionality.
Khaleafi R, Zeleznjak J, Cordela S, Drucker S, Lenac Rovis T, Jonjic S
Front Immunol. 2023; 14:1231782.
PMID: 37753084
PMC: 10518469.
DOI: 10.3389/fimmu.2023.1231782.
The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer.
Tan G, Spillane K, Maher J
Biology (Basel). 2023; 12(8).
PMID: 37626965
PMC: 10452210.
DOI: 10.3390/biology12081079.
KLF4-mediated upregulation of the NKG2D ligand MICA in acute myeloid leukemia: a novel therapeutic target identified by enChIP.
Alkhayer R, Ponath V, Frech M, Adhikary T, Graumann J, Neubauer A
Cell Commun Signal. 2023; 21(1):94.
PMID: 37143070
PMC: 10157933.
DOI: 10.1186/s12964-023-01118-z.
Inhibition of miR-20a by pterostilbene facilitates prostate cancer cells killed by NK cells via up-regulation of NKG2D ligands and TGF-β1down-regulation.
Youlin K, Simin L, Jian K, Li Z
Heliyon. 2023; 9(4):e14957.
PMID: 37064475
PMC: 10102449.
DOI: 10.1016/j.heliyon.2023.e14957.
p53 and HuR combinatorially control the biphasic dynamics of microRNA-125b in response to genotoxic stress.
Goswami B, Ahuja D, Pastre D, Ray P
Commun Biol. 2023; 6(1):110.
PMID: 36707647
PMC: 9883498.
DOI: 10.1038/s42003-023-04507-9.
OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications.
Otmani K, Rouas R, Lewalle P
Front Immunol. 2022; 13:913951.
PMID: 36189271
PMC: 9523483.
DOI: 10.3389/fimmu.2022.913951.
Application of lipid-based nanoparticles in cancer immunotherapy.
Zhang Z, Yao S, Hu Y, Zhao X, Lee R
Front Immunol. 2022; 13:967505.
PMID: 36003395
PMC: 9393708.
DOI: 10.3389/fimmu.2022.967505.
An Injectable Epigenetic Autophagic Modulatory Hydrogel for Boosting Umbilical Cord Blood NK Cell Therapy Prevents Postsurgical Relapse of Triple-Negative Breast Cancer.
Gong Y, Chen W, Chen X, He Y, Jiang H, Zhang X
Adv Sci (Weinh). 2022; 9(23):e2201271.
PMID: 35712750
PMC: 9376812.
DOI: 10.1002/advs.202201271.
Regulation of HTLV-1 transformation.
Ernzen K, Panfil A
Biosci Rep. 2022; 42(3).
PMID: 35169839
PMC: 8919135.
DOI: 10.1042/BSR20211921.
Circulating Tumor Cells: Does Ion Transport Contribute to Intravascular Survival, Adhesion, Extravasation, and Metastatic Organotropism?.
Stock C
Rev Physiol Biochem Pharmacol. 2022; 182:139-175.
PMID: 35137308
DOI: 10.1007/112_2021_68.
Manipulating the NKG2D Receptor-Ligand Axis Using CRISPR: Novel Technologies for Improved Host Immunity.
Alves E, McLeish E, Blancafort P, Coudert J, Gaudieri S
Front Immunol. 2021; 12:712722.
PMID: 34456921
PMC: 8397441.
DOI: 10.3389/fimmu.2021.712722.
Epigenetic Regulation of NK Cell-Mediated Antitumor Immunity.
Xia M, Wang B, Wang Z, Zhang X, Wang X
Front Immunol. 2021; 12:672328.
PMID: 34017344
PMC: 8129532.
DOI: 10.3389/fimmu.2021.672328.
MicroRNAs Regulating Tumor and Immune Cell Interactions in the Prediction of Relapse in Early Stage Breast Cancer.
Papadaki C, Thomopoulou K, Monastirioti A, Koronakis G, Papadaki M, Rounis K
Biomedicines. 2021; 9(4).
PMID: 33924670
PMC: 8069787.
DOI: 10.3390/biomedicines9040421.
Role of Polymorphisms of NKG2D Receptor and Its Ligands in Acute Myeloid Leukemia and Human Stem Cell Transplantation.
Machuldova A, Holubova M, Caputo V, cedikova M, Jindra P, Houdova L
Front Immunol. 2021; 12:651751.
PMID: 33868289
PMC: 8044845.
DOI: 10.3389/fimmu.2021.651751.